Navigation Links
Medical Marijuana, Inc. Reports Record First Quarter 2013 Revenue and Income
Date:4/11/2013

dedication, and to our shareholders for their continued support."

The Company reported that it intends to post its 1Q audited financial statement and disclosures on or before May 15, 2013.

About Medical Marijuana, Inc.

Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit.  We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value. 

For more information, please visit the company's website at:  www.MedicalMarijuanaInc.com

About KannaLife Sciences:

KannaLife Sciences, Inc. is a late stage bio-pharmaceutical and phyto-medical company involved in the research and development of novel new therapeutic agents designed to reduce oxidative stress, and act as immuno-modulators and neuroprotectants. KannaLife Sciences currently holds an exclusive license with National Institutes of Health – Office of Technology Transfer ("NIH-OTT") for the Commercialization of U.S. Patent 6,630,507, "Cannabinoids as Antioxidants and Neuroprotectants" (the "'507 Patent").

For more information, please visit the company's website at: www.kannalife.com

About PhytoSPHERE Systems

PhytoSPHERE Systems is the world's leading cannabinoid based Biotechnology Company that develops and builds technology specifically for the cannabis industry. This includes the research, development and production of specialty cannabis cultivars. The company acquires, develops and manages traditional cannabis agricultural facilities, as well as produces cannabinoid based high value oil, extracts and products for the wholesale and re
'/>"/>

SOURCE Medical Marijuana, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Lung Cancer Alliance Congratulates 75 Medical Centers For Moving Swiftly And Responsibly On Lung Cancer Screening
2. Medical Device Developers - Network at BIOMEDevice Boston Next Week
3. Winner Medicals Special Committee Appoints Independent Financial Advisor and Retains Legal Counsel
4. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
5. CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
6. ulrich medical USA™ Releases New Expandable Spinal Implant for US Market
7. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
8. Essential Medical Dismisses Patent Case against Masimo and Cercacor
9. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
10. Aethlon Medical Note: Marc Robins Joins the Aethlon Team
11. Enox Biopharma, Inc. To Present Today At IN3 Medical Device 360 Conference In London
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 Tegra Medical is very pleased to announce the ... new Chief Executive Officer.  Mark was promoted from his current ... the company,s four facilities in Massachusetts , ... joined Tegra Medical in 2012 with 20+ years of broad-based ...
(Date:1/15/2014)... YORK , Jan. 15, 2014 ... report is available in its catalogue: ... Forecast – Worldwide Analysis ... Market Analysis Insulin ...
(Date:1/15/2014)... CAMBRIDGE, Mass. , Jan. 15, 2014  Zafgen, ... the unmet needs of severely obese patients, today ... of beloranib, a selective inhibitor of methionine aminopeptidase ... a severe form of genetic obesity.  These results ...
Breaking Medicine Technology:Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4
... announced on August 23 the appointment of Dr. Jennifer Choo ... B.V. Dr. Choo will oversee the company,s Rose K business ... growing specialty lens portfolio. For the last 3 ... Inc. and the Brien Holden Vision Institute (BHVI) based in ...
... Therapeutics, Inc. ("CTI") (NASDAQ and MTA: CTIC) today announced ... 120 List of Outstanding Issues to the European Medicines ... Use ("CHMP") in regards to CTI,s Marketing Authorization Application ... aggressive non-Hodgkin,s lymphoma ("NHL"). With this submission, CTI expects ...
Cached Medicine Technology:Jennifer Choo Joins Menicon as Specialty Lens Clinical Manager 2Cell Therapeutics Submits Day 120 Response for Pixantrone Marketing Authorization Application to European Medicines Agency; Potential Q1 2012 Opinion on Approval 2Cell Therapeutics Submits Day 120 Response for Pixantrone Marketing Authorization Application to European Medicines Agency; Potential Q1 2012 Opinion on Approval 3
(Date:4/17/2014)... the first genetic variant specifically associated with the ... around 10-15 per cent of all breast cancer ... breast cancer sub-type, called invasive lobular carcinoma, gives ... this particular kind of breast cancer, which can ... today (Thursday) in the journal PloS Genetics ...
(Date:4/17/2014)... a study published today in PLOS Pathogens , ... malaria is common can mount an immune response to ... avoid repeated bouts of high fever and illness and ... bloodstream. The findings may help researchers develop future interventions ... malaria parasite. , Each year, approximately 200 million cases ...
(Date:4/17/2014)... Two recent papers by a University of ... help scientists develop treatments or vaccines for Dengue ... and other disease-causing flaviviruses. , Jeffrey S. Kieft, ... at the School of Medicine and an early ... and colleagues recently published articles in the scholarly ...
(Date:4/17/2014)... biology team has created a new technology for ... could travel the body and selectively target cancer ... biological devices that monitor and modify human physiology ... However, no existing technology enabled bioengineers to build ... and respond in a customized fashion. , "The ...
(Date:4/17/2014)... 10 million older Americans suffer from depression, often brought ... new research a project that followed the lives ... found that Internet use among the elderly can ... percent. , "That,s a very strong effect," said Shelia ... studies and media who led the project. "And it ...
Breaking Medicine News(10 mins):Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 3Health News:Study sheds light on how the immune system protects children from malaria 2Health News:CU researchers discover target for treating dengue fever 2Health News:Building 'smart' cell-based therapies 2Health News:Internet use can help ward off depression among elderly 2
... is one of the greatest challenges facing researchers today, and ... contain a growing epidemic.// The World Health Organization has estimated ... overweight problems, of them nearly 300 million are obese. ... that works on the source of the problem – appetite, ...
... the US have won this year's Nobel Prize for ... by double-stranded RNA, it was announced here Monday. ... in awarding them the 10-million-kronor ($1.37-million) prize. ... controlling the flow of genetic information", the institute said. ...
... recent study has revealed that children in deep sleep awoke ... name and ordering them out of their bedrooms –although they ... ,Dr. Gary Smith, one of the co-authors of the ... that what works for adults doesn't always work for children.,"Clearly, ...
... The deadly dengue viral enveloped 40 more people in the ... but the authorities// stated that the situation did not warrant ... to curb this menace. Our hospitals are well equipped to ... declare dengue as epidemic," said Health Minister Yoganand Shastri. ...
... to 100,000 people affected by chikungunya, a viral fever caused ... for confusing the state government on the nature of the ... it is not chikungunya. The government is doing its best ... and we have asked people from other systems of medicines ...
... Doctors operated upon a young man and took out at ... hospital in Tamil Nadu, which he had swallowed six months ... surprised that he lived for six months with the pin ... had swallowed apparently gone down his throat effortlessly and the ...
Cached Medicine News:Health News:Brain behind the Brawn: Vital Molecule in the Brain Controls Appetite 2Health News:Two Americans Share 2006 Nobel Medicine Prize 2Health News:Mummy’s Voice More Effective than Smoke Alarm 2Health News:Dengue Outbreak in the Capital is not an Epidemic: Government 2
Used to establish and maintain nephrostomy drainage following pyeloplasty. Supplied sterile in peel-open packages. Intended for one-time use. CAUTION: Periodic evaluation is advised; stent must not r...
... urinary diversion and drainage. The stylet is ... sheath is left in place to ease ... the access sheath is removed and discarded. ... for external catheter retention. Supplied sterile in ...
... for percutaneous placement of a ... pelvis for nephrostomy drainage in ... sterile in peel-open packages. Intended ... evaluation is advised; catheter must ...
... contains primers, a FAM-labeled probe and an Alexa ... 115 bp region of the 5' UTR. This ... Alexa 532 and Texas Red reporter dyes like ... Reagent* (ASR) program is comprised of a series ...
Medicine Products: